Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China flag China · Delayed Price · Currency is CNY
72.81
+0.11 (0.15%)
Feb 27, 2026, 3:04 PM CST

SHE:300573 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
17,94312,22922,71511,07611,2637,612
Market Cap Growth
45.82%-46.16%105.08%-1.66%47.96%29.71%
Enterprise Value
17,69711,97322,35210,57911,2267,679
Last Close Price
72.8148.7089.4043.3947.0332.62
PE Ratio
27.7236.1794.6352.3357.8586.52
PS Ratio
7.456.2915.488.8610.9611.05
PB Ratio
9.667.6813.447.148.3810.97
P/TBV Ratio
10.488.3814.097.278.5211.56
P/FCF Ratio
43.8256.03408.51-53.15543.47
P/OCF Ratio
28.2229.3371.5338.6936.6962.32
EV/Sales Ratio
7.356.1615.238.4610.9211.15
EV/EBITDA Ratio
20.1923.9565.6835.5937.7348.73
EV/EBIT Ratio
23.0329.3285.9945.7646.7268.51
EV/FCF Ratio
43.2254.85401.97-52.98548.27
Debt / Equity Ratio
0.070.140.050.010.080.12
Debt / EBITDA Ratio
0.150.420.230.050.360.51
Debt / FCF Ratio
0.330.991.42-0.535.71
Net Debt / Equity Ratio
-0.13-0.10-0.24-0.32-0.430.06
Net Debt / EBITDA Ratio
-0.28-0.31-1.18-1.69-1.930.27
Net Debt / FCF Ratio
-0.60-0.71-7.2238.70-2.713.05
Asset Turnover
1.050.940.770.720.780.76
Inventory Turnover
2.962.932.642.522.852.54
Quick Ratio
1.511.412.834.693.230.94
Current Ratio
1.901.803.485.683.691.39
Return on Equity (ROE)
37.08%20.59%14.81%14.62%20.52%14.73%
Return on Assets (ROA)
20.85%12.30%8.54%8.33%11.33%7.71%
Return on Invested Capital (ROIC)
41.91%25.63%20.13%23.01%27.40%15.12%
Return on Capital Employed (ROCE)
40.00%24.50%14.70%14.20%16.90%14.90%
Earnings Yield
3.60%2.76%1.06%1.91%1.73%1.16%
FCF Yield
2.28%1.79%0.24%-0.12%1.88%0.18%
Dividend Yield
1.10%2.20%2.11%1.26%0.50%0.28%
Payout Ratio
68.05%138.01%74.36%38.19%24.21%18.41%
Buyback Yield / Dilution
-0.66%-0.70%-0.96%-7.45%0.30%-2.88%
Total Shareholder Return
0.48%1.50%1.15%-6.19%0.80%-2.60%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.